A response by Strauss et al. to “a comment on the comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia”

William E. Strauss, N. Franklin Adkinson, Iain C. Macdougall, Michael Auerbach, Robert F. Kaper, Glenn M. Chertow, Julie S. Krop

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)E232-E233
JournalAmerican journal of hematology
Issue number9
StatePublished - Sep 2018

ASJC Scopus subject areas

  • Hematology

Cite this